MSD
Contact UsWorldwide
HomeProductsResearchAbout MSDCorporate Social ResponsibilityCareersLicensing
 

Counterfeit Medicines Information

A serious issue facing patients, health professionals and the pharmaceutical industry
Counterfeit medicines are a serious issue facing patients, health professionals and the pharmaceutical industry. They are made by someone other than the original manufacturer and whilst some counterfeit medicines may have the correct active ingredient, some are dangerous as they may:
  • be contaminated
  • include too much or too little of the active ingredient
  • contain no active ingredient
  • undermine the patients confidence in taking medicines
  • have been made in extremely unsanitary conditions
  • contain harmful or poisonous ingredients.
Merck, Sharp and Dohme takes the safety of patients extremely seriously and is working with governments and customs authorities around the world to help control the problems caused by counterfeit medicines.

For more information about counterfeit medicines, and the particular problems with counterfeit Propecia (finasteride), please visit www.propeciainfo.co.uk
Print version

 
RESEARCH

It costs about $800 million over 12 years to bring one medicine from discovery in a laboratory to the patient.
>>Read more about MSD's research in the UK
 

This site is intended for residents of the United Kingdom. Registered in England No 820771

Privacy Policy Terms of Use Copyright © 2004 [Subsidiary Name] Merck & CO., (USA)